Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study

Author:

Youn Young Chul1,Lee Byoung Sub2,Kim Gwang Je2,Ryu Ji Sun2,Lim Kuntaek2,Lee Ryan2,Suh Jeewon3,Park Young Ho3,Pyun Jung-Min3,Ryu Nayoung3,Kang Min Ju4,Kim Hye Ryoun5,Kang Sungmin2,An Seong Soo A.6,Kim SangYun3

Affiliation:

1. Department of Neurology, Chung-Ang University College of Medicine, Seoul, Republic of Korea

2. Research and Development, PeopleBio Inc., Gyeonggi-do, Republic of Korea

3. Department of Neurology, Seoul National University College of Medicine & Neurocognitive Behavior Center, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea

4. Department of Neurology, Veterans Health Service Medical Center, Seoul, Republic of Korea

5. Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea

6. Department of Bionanotechnology, Gachon University, Gyeonggi-do, Republic of Korea

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3